Table: Kubota Pharmaceutical Holdings -2023 group results (IFRS)

Kubota Pharmaceutical Holdings

18/03/2024 06:00

Mar 18 (Reuters)- 
              Kubota Pharmaceutical Holdings Co., Ltd. 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to        NEXT  
                Dec 31, 2023    Dec 31, 2022   Dec 31, 2024      YEAR    
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULT        FORECAST    H1 FORECAST 
  Sales            40 mln           8 mln                                
                (+383.3 pct)                                             
  Operating       loss 1.50       loss 2.04                              
  Pretax          loss 1.49       loss 2.02                              
  Net             loss 1.49       loss 2.02                              
  EPS Basic    loss 26.79 yen  loss 40.92 yen                            
  EPS Diluted  loss 26.79 yen  loss 40.92 yen                            
  Ann Div            NIL             NIL            NIL                  
  -Q2 Div            NIL             NIL            NIL                  
  -Q4 Div            NIL             NIL            NIL                  
 
  NOTE - Kubota Pharmaceutical Holdings Co., Ltd.. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company.
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4596.T